Procter & Gamble Co. will continue taking pricing and reinvesting in its business and underlying strategies, viewing the current economic climate as a “bottom-line rough patch to grow through.”
P&G To Test ‘Benign Elasticity’ Seen In Q2 With More Pricing Planned
“A world in which all of the market growth is driven by pricing is obviously not sustainable,” CFO Andre Schulten acknowledged in P&G’s fiscal 2023 second-quarter earnings presentation. The firm remains focused on investing in its brands and driving household penetration while weathering economic headwinds and taking additional pricing in February.

More from Earnings
Swiss firm reports highest revenues in its history as restructure pays off for its pharma and cosmetics businesses in 2024.
Coty Inc. reports fiscal second quarter sales slipped 3% on a reported basis to $1.67bn, reflecting further slowing of the mass beauty market, particularly color cosmetics.
L’Oréal Groupe expects total sales in 2025 to beat 4%-4.5% growth anticipated for the overall beauty market, with US population growth, planned innovations boding well across its beauty businesses.
Cincinnati-based P&G reports its antiperspirants/deodorants business is a ‘pocket of strength,’ growing 11% in the US in the fiscal second quarter and helping lift overall beauty sales as skin care stumbles.
More from Business
L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.
Target’s Beauty division was its strongest business unit in fiscal 2024, nearly doubling in six years to reach $13.2bn on strong in-store presentation and digital support, the retailer says.
Estee Lauder Companies collaborates with Serpin Pharma to explore anti-inflammatory innovation and skin longevity, while L’Oréal Group celebrates the grand opening of North America Research & Innovation Center with ribbon cutting event.